Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Review of Gastroenterology & Hepatology|March 10, 2017
Golimumab for moderate to severe ulcerative colitisAnne S Strik, Sophie E Berends, Ron A Mathôt, et al.
Therapeutic Drug Monitoring|July 7, 2017
Therapeutic Drug Monitoring of Gentamicin Peak Concentrations in Critically Ill PatientsCaspar J Hodiamont, Julie M Janssen, Menno D de Jong, et al.
Therapeutic Drug Monitoring|March 13, 2018
Explaining Interpatient Variability in Adalimumab Pharmacokinetics in Patients With Crohn's DiseaseSophie E Berends, Anne S Strik, Juliet C Van Selm, et al.
The Lancet. Oncology|June 13, 2015
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trialSil Kordes, Michael N Pollak, Aeilko H Zwinderman, et al.
Therapeutic Drug Monitoring|August 30, 2019
Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood SamplesSophie E Berends, Karien Bloem, Annick de Vries, et al.
American Journal of Hypertension|August 14, 2013
Nonlinear mixed effects modeling of the diurnal blood pressure profile in a multiracial populationPetra C van Rijn-Bikker, Nelleke Snelder, Oliver Ackaert, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2002
Population pharmacokinetics of the novel anticancer agent KRN7000Mirjam Crul, Ron A Mathôt, Giuseppe Giaccone, et al.
Scandinavian Journal of Gastroenterology|May 28, 2019
Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC studySophie E Berends, Anne S Strik, Jeroen M Jansen, et al.
Gastroenterology|April 29, 2015
Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative ColitisJohannan F Brandse, Gijs R van den Brink, Manon E Wildenberg, et al.
Cancers|June 2, 2021
A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with IDH1-Mutated Solid TumorsMohammed Khurshed, Remco J Molenaar, Myra E van Linde, et al.
Pageof 2